A randomised, prospective, multicenter, phase III trial of adjuvant chemotherapy with gemcitabine vs. observation in patients with resected pancreatic cancer.

被引：0
|
作者：
Neuhaus, P
Oettle, H
Post, S
Gellert, K
Ridwelski, K
Schramm, H
Zülke, C
Fahlke, G
Langrehr, J
Riess, H
机构：
[1] Stadt Klinikum Magdeburg, Berlin, Germany
[2] Waldklinikum, Gera, Germany
[3] Otto Von Guericke Univ, Magdeburg, Germany
[4] Virchow Klinikum, Charite Campus, Berlin, Germany
[5] Univ Klinikum Regensburg, Mannheim, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1092S / 1092S
页数：1
相关论文
共 50 条
  • [21] Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma
    Takada, T
    Amano, H
    Yasuda, H
    Nimura, Y
    Matsushiro, T
    Kato, H
    Nagakawa, T
    Nakayama, T
    CANCER, 2002, 95 (08) : 1685 - 1695
  • [22] ESPAC-4: A Multicenter, International, Randomized Controlled Phase III Trial of Adjuvant Combination Chemotherapy of Gemcitabine (GEM) and Capecitabine (CAP), Versus Monotherapy Gemcitabine in Patients With Resected Pancreatic Ductal Adenocarcinoma
    Neoptolemos, J. P.
    Palmer, D.
    Ghaneh, P.
    Valle, J.
    Cunningham, D.
    Wadsley, J.
    Meyer, T.
    Anthoney, A.
    Glimelius, B.
    Falk, S.
    Lind, P.
    Izbicki, J.
    Middleton, G.
    Ross, P.
    Wasan, H.
    McDonald, A.
    Crosby, T.
    Psarelli, E.
    Hammel, P.
    Buechler, M. W.
    PANCREAS, 2016, 45 (10) : 1529 - 1529
  • [23] A randomized phase II trial of neoadjuvant chemotherapy for patients with resectable pancreatic cancer: Gemcitabine alone vs. gemcitabine combined with cisplatin.
    Palmer, DH
    Stocken, DD
    Buckels, JAC
    Hewitt, H
    Markham, CE
    Mirza, D
    Johnson, PJ
    Hassan, AB
    Bramhall, SR
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 367S - 367S
  • [24] Health-related quality of life of adjuvant chemotherapy with S-1 versus gemcitabine for resected pancreatic cancer: Results from a randomised phase III trial (JASPAC 01)
    Hagiwara, Yasuhiro
    Ohashi, Yasuo
    Uesaka, Katsuhiko
    Boku, Narikazu
    Fukutomi, Akira
    Okamura, Yukiyasu
    Konishi, Masaru
    Matsumoto, Ippei
    Kaneoka, Yuji
    Shimizu, Yasuhiro
    Nakamori, Shoji
    Sakamoto, Hirohiko
    Morinaga, Soichiro
    Kainuma, Osamu
    Imai, Koji
    Sata, Naohiro
    Hishinuma, Shoichi
    Ojima, Hitoshi
    Yamaguchi, Ryuzo
    Hirano, Satoshi
    Sudo, Takeshi
    EUROPEAN JOURNAL OF CANCER, 2018, 93 : 79 - 88
  • [25] Meta analysis of recent phase III adjuvant chemotherapy trials in resected rectal cancer.
    Imtiaz, Saba
    Zekri, Jamal M.
    Al-Saadi, Rawan
    Al-Omar, Haneen
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [26] Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial
    Neoptolemos, John P.
    Palmer, Daniel H.
    Ghaneh, Paula
    Psarelli, Eftychia E.
    Valle, Juan W.
    Halloran, Christopher M.
    Faluyi, Olusola
    O'Reilly, Derek A.
    Cunningham, David
    Wadsley, Jonathan
    Darby, Suzanne
    Meyer, Tim
    Gillmore, Roopinder
    Anthoney, Alan
    Lind, Pehr
    Glimelius, Bengt
    Falk, Stephen
    Izbicki, Jakob R.
    Middleton, Gary William
    Cummins, Sebastian
    Ross, Paul J.
    Wasan, Harpreet
    McDonald, Alec
    Crosby, Tom
    Ma, Yuk Ting
    Patel, Kinnari
    Sherriff, David
    Soomal, Rubin
    Borg, David
    Sothi, Sharmila
    Hammel, Pascal
    Hackert, Thilo
    Jackson, Richard
    Buechler, Markus W.
    LANCET, 2017, 389 (10073): : 1011 - 1024
  • [27] Phase II Study of Gemcitabine and Erlotinib as Adjuvant Therapy for Patients with Resected Pancreatic Cancer
    Bao, Philip Q.
    Ramanathan, Ramesh K.
    Krasinkas, Alyssa
    Bahary, Nathan
    Lembersky, Barry C.
    Bartlett, David L.
    Hughes, Steven J.
    Lee, Kenneth K.
    Moser, A. James
    Zeh, Herbert J., III
    ANNALS OF SURGICAL ONCOLOGY, 2011, 18 (04) : 1122 - 1129
  • [28] Adjuvant gemcitabine and concurrent radiation for patients with resected pancreatic cancer: a phase II study
    A W Blackstock
    F Mornex
    C Partensky
    L Descos
    L D Case
    S A Melin
    E A Levine
    G Mishra
    S A Limentani
    L A Kachnic
    J E Tepper
    British Journal of Cancer, 2006, 95 : 260 - 265
  • [29] Phase II Study of Gemcitabine and Erlotinib as Adjuvant Therapy for Patients with Resected Pancreatic Cancer
    Philip Q. Bao
    Ramesh K. Ramanathan
    Alyssa Krasinkas
    Nathan Bahary
    Barry C. Lembersky
    David L. Bartlett
    Steven J. Hughes
    Kenneth K. Lee
    A. James Moser
    Herbert J. Zeh
    Annals of Surgical Oncology, 2011, 18 : 1122 - 1129
  • [30] Adjuvant gemcitabine and concurrent radiation for patients with resected pancreatic cancer: a phase II study
    Blackstock, A. W.
    Mornex, F.
    Partensky, C.
    Descos, L.
    Case, L. D.
    Melin, S. A.
    Levine, E. A.
    Mishra, G.
    Limentani, S. A.
    Kachnic, L. A.
    Tepper, J. E.
    BRITISH JOURNAL OF CANCER, 2006, 95 (03) : 260 - 265
12345